Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 19 of 99

  1. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Relapsed Non-Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  2. BGB-21447

    BEONE MEDICINES AUS PTY LTD

    Hormone-receptor-positive Breast Cancer

    phase 1 small molecule active

    1 trial

  3. BGB-21447-101

    BeiGene

    mature B-Cell malignancies

    phase 1 other active

    1 trial

  4. BGB-24714

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor, Adult

    phase 1 small molecule terminated

    1 trial

  5. BGB-26808

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  6. BGB-3227-101

    BEONE MEDICINES AUS PTY LTD

    Solid tumors

    phase 1 other active

    1 trial

  7. BGB-43395

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  8. BGB-43395-101

    BEONE MEDICINES AUS PTY LTD

    Advanced or metastatic solid tumors including hormone receptor positive (HR+), human epidermal growth factor 2 negative (HER2-) breast cancer

    phase 1 other active

    1 trial

  9. BGB-45035

    BEONE MEDICINES AUS PTY LTD

    Healthy Participants

    phase 1 small molecule active

    1 trial

  10. BGB-53038

    BEONE MEDICINES AUS PTY LTD

    Metastatic Solid Tumors

    phase 1 small molecule active

    1 trial

  11. BGB-53038-101

    BEONE MEDICINES AUS PTY LTD

    Advanced or Metastatic Solid Tumors with KRAS Mutations or Amplifications

    phase 1 other active

    1 trial

  12. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

  13. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  14. BGB-58067

    BEONE MEDICINES AUS PTY LTD

    Glioblastoma (GBM)

    phase 1 small molecule active

    1 trial

  15. BGB-A3055

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule terminated

    1 trial

  16. BGB-A317-A3055-101

    BeiGene

    Advanced or metastatic solid tumors

    phase 1 other active

    1 trial

  17. BGB-B2033

    BEONE MEDICINES AUS PTY LTD

    Metastatic Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  18. BGB-B2033-101

    BEONE MEDICINES AUS PTY LTD

    Selected Advanced or Metastatic Solid Tumors

    phase 1 other active

    1 trial

  19. BGB-B3227

    BEONE MEDICINES AUS PTY LTD

    Advanced Cancer

    phase 1 small molecule terminated

    1 trial

  20. BGB-B455

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  21. BGB-C354

    BEONE MEDICINES AUS PTY LTD

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  22. BGB-R046

    BEONE MEDICINES AUS PTY LTD

    Solid Tumor

    phase 1 small molecule terminated

    1 trial

  23. BGM-2121

    Chongqing Precision Biotech Co., Ltd

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  24. BHV-1300

    Biohaven Bioscience Ireland Limited

    Graves Disease

    phase 1 small molecule active

    1 trial

  25. BHV2100-112

    Biohaven Bioscience Ireland Limited

    Pain

    phase 1 other active

    1 trial

  26. BI 1015550, NERANDOMILAST

    Boehringer Ingelheim

    Healthy volunteer trial

    phase 1 small molecule active

    1 trial

  27. BI 3011441

    Boehringer Ingelheim

    Solid Tumors, KRAS Mutation

    phase 1 small molecule completed

    1 trial

  28. BI 695502

    Boehringer Ingelheim

    Healthy

    phase 1 small molecule completed

    1 trial

  29. BI 765063

    Boehringer Ingelheim

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 1 small molecule active

    1 trial

  30. BI 905711

    Boehringer Ingelheim

    Gastrointestinal Neoplasms

    phase 1 small molecule completed

    1 trial

  31. BIA-28-6156-111

    Bial Portela & Companhia S.A.

    Parkinson's disease

    phase 1 other active

    1 trial

  32. BIA-28-6156-113

    BIAL - Portela & Ca

    Healthy volunteers

    phase 1 other active

    1 trial

  33. BICX104

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  34. BICX104 naltrexone implantable pellet

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Adult Male and Female Volunteers

    phase 1 small molecule active

    1 trial

  35. BIIB094

    IONIS PHARMACEUTICALS INC

    Parkinson's Disease

    phase 1 small molecule completed

    1 trial

  36. BIIB115

    Biogen

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  37. BIIB122 (DNL151)

    Denali Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  38. BIO 300 Oral Powder

    United Therapeutics Europe Ltd

    Acute Radiation Syndrome

    phase 1 small molecule completed

    1 trial

  39. BIOPIN-6 Active Implant with Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 other completed

    1 trial

  40. BIS-001 ER

    SUPERNUS PHARMACEUTICALS, INC.

    Epilepsy, Complex Partial

    phase 1 small molecule completed

    1 trial

  41. BL-M07D1

    Sichuan Baili Pharmaceutical Co.,

    Breast Cancer

    phase 1 small molecule active

    1 trial

  42. BLCL-2ME-01

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  43. BLCL-2ME-02

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  44. BLCL-ACB-PIL01

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  45. BLCL-AMC-01

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

  46. BLCL-AMC-02

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

  47. BLCL-AMC-03

    BIAL - Portela & Ca

    No medical condition.

    phase 1 other active

    1 trial

  48. BLCL-CAB-PIL01

    Lacuna Pharma Pty Ltd

    No medical condition.

    phase 1 other active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.